Monday, November 28, 2011

Coming soon: The separated-at-birth hits (Politico)

A source sends over this unreleased Web video from Senate candidate Steve Welch of Pennsylvania, which asks if Democratic Sen. Bob Casey was ?separated at birth? from President Barack Obama.

Except this one doesn?t just ask the question rhetorically. The video is a faux documentary exploring the possibility that Casey and Obama are related, featuring fictional experts such as behavioral scientist Dr. Arthur Herberstein and probability expert Dr. Milo Kamdermann.

Continue Reading

The video is a clever and well produced new take on a familiar Republican attack line and a sign of things to come for swing-state Senate and House races next year.

Right now, a candidate like Welch ? a wealthy entrepreneur making his first bid for statewide office ? is looking to make a splash in a GOP primary. (Call him a "separated-at-birther"?) But this kind of hit against Casey sets the stage for a general election in which Obama?s coattails could very well be determinative.

UPDATE: Matt Canter, communications director for the Democratic Senatorial Campaign Committee, scoffed at the Welch attack. "Congrats to some consultant who made a pretty penny on a web video no one will see," Canter said.?"Can't wait to watch the next episode about Welch, the guy who actually voted for Obama and now pretends he is a tea partier. But Welch is only polling at one percent right now, so he would never warrant a web video."

Source: http://us.rd.yahoo.com/dailynews/rss/politics/*http%3A//us.rd.yahoo.com/dailynews/external/politico_rss/rss_politico_mostpop/http___www_politico_com_news_stories1111_69142_html/43726274/SIG=11mo28ipr/*http%3A//www.politico.com/news/stories/1111/69142.html

when will ios 5 be released ipod nano watch ipod nano watch dancing with the stars elimination dancing with the stars elimination nexus prime nexus prime

Saturday, November 26, 2011

S&P cuts Egypt sovereign rating (AP)

CAIRO ? Ratings agency Standard & Poor's says it has cut Egypt's sovereign credit rating, pushing it deeper into junk status on the back of the country's political turmoil and its weak economic profile.

S&P said Thursday it cut Egypt's long-term foreign and local currency sovereign ratings to B+ from BB-, with a negative outlook.

The agency says the cuts reflect its opinion that Egypt's "weak political and economic profile" had deteriorated further.

The cut comes after days of clashes between protesters and security forces in central Cairo ? battles that raised questions about the country's political situation days before the scheduled Nov. 28 parliamentary elections.

The vote is the first since former President Hosni Mubarak was ousted from power in February.

Source: http://us.rd.yahoo.com/dailynews/rss/economy/*http%3A//news.yahoo.com/s/ap/20111124/ap_on_bi_ge/ml_egypt_economy

uekman uekman music awards music awards giants eagles bcs rankings week 13 bcs rankings week 13

Microsoft comments on Siri, proves they still don?t get it

In an interview with Forbes, Microsoft’s Chief Research and Strategy Officer Craig Mundie poopoos Apple’s Siri intelligent virtual assistant as unoriginal, and nothing Microsoft’s TellMe hasn’t been doing since the introduction of Windows Phone 7.
You can take these Windows Phones now and you can just pick
...


Source: http://feedproxy.google.com/~r/TheIphoneBlog/~3/hPkwgDDBp-E/story01.htm

san onofre the little couple bubba smith bubba smith oakland strike new gmail new gmail

New Zealand votes as PM seeks outright majority (AP)

WELLINGTON, New Zealand ? New Zealanders voted in national elections Saturday, with popular Prime Minister John Key seeking to propel his center-right party to the country's first outright parliamentary majority in years.

Polling stations closed at 7 p.m. local time (0600 GMT; 1 a.m. EST), with a winner expected to emerge by 10 p.m. (0900 GMT; 4 a.m. EST).

Both Key and his main opponent, Labour Party leader Phil Goff, cast their ballots early in Auckland polling stations. If either man had anything political to say, local media weren't reporting it ? thanks to a ban in New Zealand on election day coverage that might influence voters.

The coverage ban extends to signs and placards, which were all taken down overnight.

If opinion polls hold, Key's National Party would be the first party to secure a majority on its own since the country abolished a winner-take-all voting system and replaced it in 1996 with a proportional one that generally results in a more fractured parliament.

Anything short of a majority, however, and Key will need to find political partners to form a stable government.

What's not in doubt is Key's personal popularity ? despite a scandal in recent days over a recorded conversation. After three years in power, polls show the former currency trader is far more popular than Goff. Key has earned the nickname "Teflon John" for the way that nothing politically damaging seems to stick to him.

"He's a clever strategist and a good manager," said Jennifer Lees-Marshment, a political studies lecturer at the University of Auckland.

She said Key has been adept at knowing when to forge ahead with policies and when to pull back. His common touch was reassuring to people when a deadly earthquake struck Christchurch in February, she said, and enabled him to share in their excitement in October when the country's national All Blacks team won the Rugby World Cup.

Key's campaign has focused primarily on the economy. He's promising to bring the country back into surplus and begin paying down the national debt within three years. Part of his plan to achieve that is to sell minority stakes in four government-owned energy companies and in Air New Zealand.

That's where the center-left Labour party has found its biggest point of difference. Goff is promising not to sell anything and to raise money by other means, including by introducing a capital gains tax and by raising the age at which people get government pensions by two years to 67.

On the campaign trail, however, those issues got crowded out by a mini-scandal known as the teapot tape saga. While he met at tea shop with a political ally, Key reportedly made rude and embarrassing political comments that were captured on a recording device left by a cameraman.

The tape has never been publicly aired, although opponents, who may have been leaked transcripts, claim the prime minister said that elderly supporters of one opposition party were dying out and also disparaged the leadership of another party. Three days before the election, police began serving search warrants on four media outlets, seeking the tape and related material on the grounds that it is illegal to tape a private conversation.

The cameraman says he left the device inadvertently, and besides, the conversation could hardly be considered private given that media were invited there by Key for an earlier photo opportunity.

Lees-Marshment said she thinks voters grew tired of the attention given to the story and may have begun feeling more sympathetic toward Key.

"It became a story about the story," she said. "The voters got put off by it."

The saga certainly didn't seem to do much to boost the campaign of Goff, who was effectively shut out of any coverage for a few days. Labour's lackluster polling, about 28 percent, has pundits speculating Goff will be replaced as leader of the party within days of the election.

But the saga did seem to boost the fortunes of Winston Peters, who leads the small New Zealand First party. Peters grabbed the headlines with pointed criticism of Key over the affair and his poll numbers shot up.

Another winner in the election is likely to be the Green party, which is polling about 12 percent, putting it on target for its best ever showing.

Voters will also decide whether to keep their electoral system, in which parties get a proportion of parliamentary seats based on the proportion of the votes they receive. Some want to return to a winner-takes-all format, although polls indicate most favor sticking with their current system.

(This version corrects EST times of poll closings in paragraph 2. Recorrects GMT times.)

Source: http://us.rd.yahoo.com/dailynews/rss/asia/*http%3A//news.yahoo.com/s/ap/20111126/ap_on_re_as/as_new_zealand_election

albert haynesworth banana republic apple store academy barnes and noble nook bcs rankings

Friday, November 25, 2011

Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds (HealthDay)

TUESDAY, Nov. 22 (HealthDay News) -- British researchers have good news for anyone taking the cholesterol-lowering medications known as statins: These drugs are effective and safe, even when used for long periods of time, they say.

The 11-year study found that simvastatin (brand name Zocor) reduced the risk of cardiovascular disease by almost one-quarter. In addition, the researchers found no increase in illness or deaths from cancer or other non-vascular causes.

"All those at increased vascular risk should start taking statins early and continue taking them long term," said the study's lead author, Dr. Richard Bulbulia, a consultant vascular surgeon and research fellow in the clinical trial service unit at the University of Oxford in England.

"This will maximize the reductions in heart attacks, strokes and other vascular diseases, and is safe," said Bulbulia, who added that the study's findings should provide reassurance to physicians and their patients.

There are numerous other drugs in this class of medication, and Bulbulia said, "it seems reasonable to assume that [this study's findings] should hold true for other currently prescribed statins." Other commonly used statins include Lipitor, Crestor and Mevacor.

Results of the study are published in the Nov. 23 online issue of The Lancet. Funding for the study was provided by the U.K. Medical Research Council, the British Heart Foundation, Merck & Co. (manufacturer of Zocor) and Roche Vitamins.

The study looked at the long-term safety of simvastatin because some research suggested that the rates of some cancers and non-vascular health conditions were increased in people who had lower levels of LDL (bad) cholesterol.

Initially, the study recruited more than 20,500 people who had a high risk of heart disease and other cardiovascular problems for a trial of simvastatin versus a placebo. The study volunteers were between 40 and 80 years old.

Half the group was randomly assigned to take 40 milligrams of simvastatin daily, while the other half took a placebo. At the end of the treatment phase of the trial, which lasted about five years, study participants were encouraged to continue on their study treatment for as long as another six years. About 17,500 of the initial participants continued in the follow-up phase, according to the report.

People taking simvastatin reduced their "bad" cholesterol an average of 1 millimole per liter over five years. This reduction translated into a 23 percent drop in the risk of major cardiovascular events, such as heart attack and stroke, the researchers said. This benefit continued throughout the follow-up, reported the study.

When the researchers examined the data from the treatment and follow-up phases for evidence of any increases in non-vascular events, such as cancer, they found no significant differences between the two groups.

"Statin therapy appears safe, with no hazards, such as an excess risk of cancer or other major non-vascular morbidity or mortality emerging during the 11-year post-trial period," said Bulbulia.

Another expert praised statins' record.

"I think the statin drugs are an extraordinary class of medications, and a necessity in Western populations, where there is less physical exercise and more calorie consumption," said Dr. Howard Weintraub, clinical director of the Center for the Prevention of Cardiovascular Disease at NYU Langone Medical Center in New York City.

"These are very safe drugs, and this study demonstrates that safety, and that the vascular protection continues well beyond the termination of treatment," said Weintraub.

"I think the picture for cardiovascular disease would be very different if these drugs weren't a part of our armamentarium," he added.

More information

Learn more about statins from the U.S. Food and Drug Administration.

Source: http://us.rd.yahoo.com/dailynews/rss/meds/*http%3A//news.yahoo.com/s/hsn/20111123/hl_hsn/cholesterolloweringdrugssafeforlongtermusestudyfinds

widespread panic widespread panic richard stallman richard stallman williston north dakota williston north dakota kody brown